COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

November 01, 2024 00:22:22
Episode Cover

Naloxone for OHCA?

The incidence of opioid-associated out-of-hospital cardiac arrests continues to rise.  Current guidelines for the resuscitation of patients with OHCA advise the clinician to consider...

Listen

Episode 0

September 17, 2019 00:19:53
Episode Cover

Do ED-Based ICUs Make a Difference?

Over the past decade, the annual hours of critical care delivered in US emergency departments has sharply risen. Undoubtedly, many critically ill patients remain...

Listen

Episode 0

December 31, 2018 00:37:34
Episode Cover

Top Articles of 2018

A plethora of great articles pertaining to the care of critically ill patients were published in 2018.  In this podcast, we review some of...

Listen